FR
Solutions
Consulting
Products
Lab'O
Contact us
FR
EN
Menu
Tag: Metabolic conditions
Scientific communications
SPUR™ Phase 2 US study: final results
Scientific communications
SPUR™ Phase 2 UK study: interim results
Success Stories
Designing a global patient support program blueprint
Scientific communications
Inodiab study: improvement of type 2 diabetes patients’ adherence
Success Stories
Outcomes of a pharmacist intervention on diabetic patients
Small Talk Big Issues
Pharma: let’s become healthcare providers - Etienne Tichit
Press / Media
Mycontrol support, a new collaboration on obesity in Norway
Accès plateformes
English
Français
English
Improve patients' lives
Solutions
Understand
Personalize
Engage
Improve
Consulting
Insight generation
Implementation support
Go-to-market strategies
Products
Lab'O
The Lab Bench
The Garage
Observia
Discover us
Purpose
Story
Join us
Get in touch
Contact us
Newsletter
Follow us
insights
Press / Media
New study results show SPUR™ tool predicts hospital admission and early readmission
events
11
oct
Events
Observia at Reuters Pharma
Oct 11
st
2022 at 08h00
